- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01840358
Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
April 25, 2013 updated by: Patricia Olivier, St. Justine's Hospital
Evaluation of the Frequency of Hypoglycemia at Initiation of Insulin Pump Therapy in Children With Type 1 Diabetes
The purpose of this study is to determine if patients have more hypoglycemic episodes the first 3 days following pump start compared to their usual number of hypoglycemias with our actual pump initiation protocol.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Patricia Olivier, MD
- Phone Number: 5486 514-345-4931
- Email: patricia.olivier.hsj@ssss.gouv.qc.ca
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1C5
- Recruiting
- CHU Sainte-Justine
-
Contact:
- Patricia Olivier, MD
- Phone Number: 5486 514-345-4931
- Email: patricia.olivier.hsj@ssss.gouv.qc.ca
-
Principal Investigator:
- Patricia Olivier, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with type 1 diabetes with follow-up at the CHU Sainte-Justine
- Patient about to start insulin pump therapy at the CHU Sainte-Justine
- Last HbA1c between 7.2 and 9.7%
- Informed and signed consent
Exclusion Criteria:
- Type 1 diabetes diagnosed less than 1 year ago WITH total daily dose of insulin < 0.5U/kg/day
- Home of the patient at more than 50km of the CHU Sainte-Justine
- Refusal to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients starting pump therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of hypoglycemias
Time Frame: 6 days
|
Frequency of hypoglycemias defined as blood sugars < 4.0mmol/l
|
6 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of hyperglycemias
Time Frame: 6 days
|
Frequency of hyperglycemias defined as blood sugars > 17.0mmol/L
|
6 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: patricia Olivier, Md, St. Justine's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
April 22, 2013
First Submitted That Met QC Criteria
April 22, 2013
First Posted (Estimate)
April 25, 2013
Study Record Updates
Last Update Posted (Estimate)
April 26, 2013
Last Update Submitted That Met QC Criteria
April 25, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSJ-3638
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Observation of hypoglycemias frequency 3 days before and after pump initiation
-
Hospices Civils de LyonRecruiting
-
Centre Hospitalier Universitaire DijonCompleted
-
Nantes University HospitalCompiègne University of TechnologyCompleted
-
Hetty CarrawayActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Lei LiUnknownDeep Venous Thrombosis | Gynecologic Neoplasm | Ankle Motion | Abdominal BreathingChina
-
University of CopenhagenDepartment of Biomedical Sciences; XLab, Center of Healthy AgingCompletedType 2 Diabetes and ExerciseDenmark
-
UMC UtrechtDutch Health Care Insurance BoardCompletedSevere Communtity-Acquired PneumoniaNetherlands
-
Singapore General HospitalCompletedBleeding Peptic Ulcers DiseaseSingapore
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Biokosmes SrlOpera CRO, a TIGERMED Group CompanyCompletedOral Hygiene | Dental Plaque | ToothbrushingItaly